These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1589 related items for PubMed ID: 15569111

  • 1. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A, Franceschi M, Leandro G, Paris F, Cascavilla L, Longo MG, Niro V, Andriulli A, Scarcelli C, Di Mario F.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1091-7. PubMed ID: 15569111
    [Abstract] [Full Text] [Related]

  • 2. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK, Graham DY.
    Aliment Pharmacol Ther; 2004 May 15; 19(10):1051-61. PubMed ID: 15142194
    [Abstract] [Full Text] [Related]

  • 3. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct 15; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 4. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
    Ray WA, Chung CP, Stein CM, Smalley WE, Hall K, Arbogast PG, Griffin MR.
    Gastroenterology; 2007 Sep 15; 133(3):790-8. PubMed ID: 17854591
    [Abstract] [Full Text] [Related]

  • 5. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
    Goldstein JL, Howard KB, Walton SM, McLaughlin TP, Kruzikas DT.
    Clin Gastroenterol Hepatol; 2006 Nov 15; 4(11):1337-45. PubMed ID: 17088110
    [Abstract] [Full Text] [Related]

  • 6. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov 15; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 7. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D.
    J Rheumatol; 2002 Mar 15; 29(3):467-73. PubMed ID: 11908558
    [Abstract] [Full Text] [Related]

  • 8. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Vergara M, Catalán M, Gisbert JP, Calvet X.
    Aliment Pharmacol Ther; 2005 Jun 15; 21(12):1411-8. PubMed ID: 15948807
    [Abstract] [Full Text] [Related]

  • 9. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
    Yeomans ND.
    Ital J Gastroenterol Hepatol; 1999 Jun 15; 31 Suppl 1():S89-92. PubMed ID: 10379475
    [Abstract] [Full Text] [Related]

  • 10. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.
    Pilotto A, Franceschi M, Leandro G, Paris F, Niro V, Longo MG, D'Ambrosio LP, Andriulli A, Di Mario F.
    Aging Clin Exp Res; 2003 Dec 15; 15(6):494-9. PubMed ID: 14959953
    [Abstract] [Full Text] [Related]

  • 11. Peptic ulcer disease today.
    Yuan Y, Padol IT, Hunt RH.
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb 15; 3(2):80-9. PubMed ID: 16456574
    [Abstract] [Full Text] [Related]

  • 12. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B, Xia HH, Ma CW, Wong KW, Fung FM, Hui CK, Chan CK, Chan AO, Lai KC, Yuen MF, Wong BC.
    Aliment Pharmacol Ther; 2005 Aug 01; 22(3):243-9. PubMed ID: 16091062
    [Abstract] [Full Text] [Related]

  • 13. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.
    Rheumatology (Oxford); 2003 Nov 01; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [Abstract] [Full Text] [Related]

  • 14. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1999 Nov 01; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [Abstract] [Full Text] [Related]

  • 15. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
    Lanas A, García-Rodríguez LA, Arroyo MT, Bujanda L, Gomollón F, Forné M, Aleman S, Nicolas D, Feu F, González-Pérez A, Borda A, Castro M, Poveda MJ, Arenas J, Investigators of the Asociación Española de Gastroenterología (AEG).
    Am J Gastroenterol; 2007 Mar 01; 102(3):507-15. PubMed ID: 17338735
    [Abstract] [Full Text] [Related]

  • 16. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S, Ittel TH, Wietholtz H.
    Z Gastroenterol; 2003 Aug 01; 41(8):719-28. PubMed ID: 12910426
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease.
    Höer A, Gothe H, Schiffhorst G, Sterzel A, Grass U, Häussler B.
    Pharmacoepidemiol Drug Saf; 2007 Aug 01; 16(8):854-8. PubMed ID: 17323403
    [Abstract] [Full Text] [Related]

  • 18. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C, Pelosini I.
    Ital J Gastroenterol Hepatol; 1999 Aug 01; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [Abstract] [Full Text] [Related]

  • 19. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
    Vonkeman HE, Fernandes RW, van der Palen J, van Roon EN, van de Laar MA.
    Arthritis Res Ther; 2007 Aug 01; 9(3):R52. PubMed ID: 17521422
    [Abstract] [Full Text] [Related]

  • 20. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
    Russell RI.
    Ital J Gastroenterol Hepatol; 1997 Oct 01; 29(5):465-9. PubMed ID: 9494858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 80.